e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Novel pharmacological findings in the management of respiratory disorders
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Development and validation of an innovative self-administered computerized (SAC) version of baseline/transition dyspnea index (BDI/TDI) for evaluating breathlessness in patients with COPD: The BLAZE study
D. A. Mahler, V. Brunel, T. White, V. Alagappan, H. Chen, K. Kulich, N. Gallagher, D. Banerji (Hanover, East Hanover, United States Of America; Lyon, France; Basel, Switzerland; Horsham, United Kingdom)
Source:
Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Session:
Novel pharmacological findings in the management of respiratory disorders
Session type:
Thematic Poster Session
Number:
718
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. A. Mahler, V. Brunel, T. White, V. Alagappan, H. Chen, K. Kulich, N. Gallagher, D. Banerji (Hanover, East Hanover, United States Of America; Lyon, France; Basel, Switzerland; Horsham, United Kingdom). Development and validation of an innovative self-administered computerized (SAC) version of baseline/transition dyspnea index (BDI/TDI) for evaluating breathlessness in patients with COPD: The BLAZE study. Eur Respir J 2013; 42: Suppl. 57, 718
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Testing the validity of a self-administered questionnaire version of the transition dyspnea index in COPD patients
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016
Responsiveness of dyspnea through the pulmonary function status and dyspnea questionnaire – Modified version (PFSDQ-M) post different training programs in patients with COPD
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD
Year: 2013
Multidimensional evaluation of dyspnea in COPD: An observational field-study
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
QVA149 provides significant symptomatic benefit to COPD patients as measured by a new symptom e-diary: The SHINE study
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Baseline symptom scores and future risk of severe exacerbation: The SPARK study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
The relationship between dyspnea and detection of depression in COPD patients (pts)
Source: International Congress 2015 – Different data in COPD
Year: 2015
Translation, validity and reliability of the Leicester cough questionnaire into Swedish in COPD
Source: International Congress 2016 – Physiotherapy management of the ill but spontaneously-breathing adult patient
Year: 2016
CAT (COPD assessment test) in the initial assessment for pulmonary rehabilitation program
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013
Correlation between COPD assessment test (CAT) and mMRC dyspnea scale in evaluationg COPD symptoms
Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Year: 2019
Validtiy and usability testing of the Fitbit pedometer in patients with COPD
Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods
Year: 2015
Development of a Barthel index based on dyspnea for patients with respiratory diseases
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016
Benefits of the LAMA/LABA glycopyrronium (GP)/formoterol (FF) MDI FDC, delivered using a novel MDI co-suspension technology (GFF MDI), increase with baseline symptom severity in COPD patients (pts)
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
Comparison of modified medical research council scale and COPD assessment test in subjects with COPD
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
Agreement between patient-reported and chart documented outcomes: Case study in COPD
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Indacaterol/glycopyrronium (IND/GLY) is superior to salmeterol/fluticasone (SFC) in improving the health status of patients with moderate-to-very severe COPD: Results from the FLAME study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
Comparing the chronic respiratory questionnaire-self report (CRQ-SR) and the breathing problems questionnaire (short version) (BPQ-SV) as a quality of life outcome measure for pulmonary rehabilitation (PR)
Source: Annual Congress 2007 - Rehabilitation: measuring, monitoring and maintenance
Year: 2007
A randomised controlled trial of cognitive behavioural therapy (CBT) delivered by respiratory nurses to reduce anxiety in chronic obstructive pulmonary disease (COPD). (Trial registration - ISCRCTN55206395)
Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences
Year: 2016
BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity?
Source: International Congress 2014 – Clinical presentations
Year: 2014
Inhaler competence and patient satisfaction with a DPI; results of two real-life studies in asthma and COPD
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept